CIRM’s mission, under the authority of Proposition 71, is to accelerate stem cell treatments to patients with unmet medical needs. CIRM has undertaken this strategic planning process in an effort to optimize its performance over the next five-year period (2016-2020). This period was selected because it is the timeframe for which the Institute is certain to have funds available to make additional investments.
Learn more about our Strategic Plan here.
Find out more: